Stockscreener 앱 받기
5.03
1.18%
-0.06
시간 외 거래:
5.04
0.010
+0.20%
전일 마감가:
$5.09
열려 있는:
$5.01
하루 거래량:
1.48M
Relative Volume:
0.65
시가총액:
$1.86B
수익:
$10.27B
순이익/손실:
$120.00M
주가수익비율:
12.14
EPS:
0.4142
순현금흐름:
$949.99M
1주 성능:
-0.40%
1개월 성능:
-15.18%
6개월 성능:
-25.26%
1년 성능:
-28.14%
1일 변동 폭
$4.945
$5.095
1주일 범위
$4.93
$5.29
52주 변동 폭
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
명칭
Bausch Health Companies Inc
전화
514-744-6792
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
5.03 | 1.89B | 10.27B | 120.00M | 949.99M | 0.4142 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 56.96B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.99 | 49.54B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.90B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.44 | 34.48B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
527.00 | 23.24B | 3.18B | 1.33B | 1.04B | 27.90 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2024-08-02 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | 개시 | Raymond James | Mkt Perform |
| 2023-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-06-13 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-02-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-24 | 개시 | Citigroup | Buy |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-02 | 개시 | Goldman | Neutral |
| 2019-10-25 | 개시 | Cowen | Outperform |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-08-15 | 업그레이드 | TD Securities | Hold → Buy |
| 2019-07-19 | 개시 | Wolfe Research | Outperform |
| 2019-06-11 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-01-02 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | 업그레이드 | Piper Jaffray | Underweight → Neutral |
모두보기
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health Cos Inc. $BHC is Goldentree Asset Management LP's Largest Position - MarketBeat
Aug Big Picture: What drives Bausch Health Companies Incs stock priceWeekly Stock Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Merger Talk: Is Bausch Health Companies Inc subject to activist investor interestQuarterly Trade Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Aug Momentum: Is Bausch Health Companies Inc backed by strong institutional buying2026 Analyst Calls & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
VIX Spike: Can Bausch Health Companies Inc expand into new marketsEarnings Growth Report & Fast Moving Stock Trade Plans - baoquankhu1.vn
Separation overhang continues to weigh on Bausch Health Companies Inc. (BHC) outlook - MSN
Bausch Health Cos Inc. $BHC Shares Sold by Compass Rose Asset Management LP - MarketBeat
Q2 EPS Forecast for Bausch Health Cos Decreased by Analyst - MarketBeat
Zacks Research Issues Positive Estimate for TSE:BHC Earnings - MarketBeat
BHC Stock Price, Quote & Chart | BAUSCH HEALTH COS INC (NYSE:BHC) - ChartMill
Zacks Research Expects Lower Earnings for Bausch Health Cos - MarketBeat
Zacks Research Has Pessimistic View of TSE:BHC Q1 Earnings - MarketBeat
Growth Value: Is Bausch Health Companies Inc impacted by rising ratesRecession Risk & Safe Entry Point Alerts - baoquankhu1.vn
Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug price‑fixing case - Reuters
Bausch Health Companies (TSE:BHC) Stock Price Down 1.1%Here's What Happened - MarketBeat
Bausch Health (BHC) announces global phase 3 RED-C clinical program results - MSN
Bausch Health to redeem ~$602M of outstanding notes due 2026 - MSN
How analysts rate Bausch Health Companies Inc. stock todayAnalyst Upgrade & Step-by-Step Trade Execution Guides - Naître et grandir
Vanguard Group Inc. Has $78.81 Million Stock Holdings in Bausch Health Cos Inc. $BHC - MarketBeat
Bausch Health expects 3% revenue growth in 2026 while strengthening balance sheet and expanding in China - MSN
BHC SEC FilingsBausch Health Companies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
List of 22 Acquisitions by Bausch Health (Mar 2026) - Tracxn
Bausch Health (NYSE: BHC) CFO reports tax-withholding share disposition - Stock Titan
Bausch Health (BHC) EVP Carson trades shares, settles equity awards - Stock Titan
Tax withholding and cash PSU settlement for Bausch Health (BHC) CEO - Stock Titan
Seana Carson reports sales of 8,388 and 6,856 shares — BHC (NYSE: BHC) - Stock Titan
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs - Investing.com Canada
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs By Investing.com - Investing.com Australia
Bausch Health (NYSE: BHC) converts 2023 executive PSUs into cash-settled awards - Stock Titan
Bausch Health (NYSE:BHC) Stability Story Amid Canada Pharma Shifts Nyse Composite Today - Kalkine Media
Proposed insider sale at BHC (NYSE: BHC) — 6,856 common shares - Stock Titan
Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Reduce" from Analysts - MarketBeat
Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines? - Sahm
Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts - Sahm
Bausch Health (BHC) SVP Steven Lee receives 45,868 restricted share units - Stock Titan
Bausch Health (NYSE: BHC) EVP receives RSU grant, tax shares withheld - Stock Titan
Insider moves at Bausch Health (BHC): RSU grant, tax shares, open-market sale - Stock Titan
Bausch Health (NYSE: BHC) CFO awarded RSUs; shares withheld for tax obligations - Stock Titan
Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC? - Yahoo Finance
BHC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bausch Health Cos (NYSE:BHC) Price Target Cut to $7.00 by Analysts at Barclays - MarketBeat
Signal Recap: Is now the right time to enter SAIAQuarterly Market Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
EV Market: Is Bausch Health Companies Inc backed by strong institutional buyingMarket Volume Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors - DirectorsTalk Interviews
Trading Recap: Is Bausch Health Companies Inc stock a value trapJuly 2025 Gainers & Free Community Consensus Stock Picks - baoquankhu1.vn
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook - Insider Monkey
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada - PR Newswire
New anti-aging laser lets Canadian clinics target wrinkles, spots, pores - Stock Titan
Bausch Health Weighs China Aesthetics Push Against ARESTIN Milestone And Debt - Yahoo Finance
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Fennec Pharmaceuticals (FENC) and InfuSystem Holdings (INFU) - The Globe and Mail
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now? - sharewise.com
Bausch Health Companies Inc (BHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.77%
자본화:
|
볼륨(24시간):